Decreased maximal aerobic capacity in pediatric chronic kidney disease

Abstract

Adult and pediatric patients with ESRD have impaired maximum oxygen consumption (VO(2) max), a reflection of the cardiopulmonary system's ability to meet increased metabolic demands. We sought to determine factors associated with decreased VO(2) max in pediatric patients with different stages of CKD. VO(2) max was measured using a standardized exercise testing protocol in patients with stage 2 to 4 chronic kidney disease (CKD) (n = 46), in renal transplant recipients (n = 22), in patients treated with maintenance hemodialysis (n = 12), and in age-matched healthy controls (n = 33). VO(2) max was similar between children with stage 2 CKD and controls, whereas lower VO(2) max was observed among children with stage 3 to 4 CKD, those treated with hemodialysis, and transplant recipients. In univariate analysis, VO(2) max was significantly associated with body mass index, resting heart rate, C-reactive protein, serum triglycerides, serum creatinine, and measures of diastolic function; no significant associations with left ventricular structure or systolic function were identified. In multivariate regression analysis, patient category versus control and the presence of diastolic dysfunction were independent predictors of lower VO(2) max. These results suggest that aerobic capacity is decreased in the early stages of CKD in children and that lower VO(2) max can be predicted by the presence of diastolic dysfunction, even if systolic function is normal.

Figure 1.

Maximum oxygen consumption (VO₂ max) in pediatric patients with CKD. Data represented as mean ± SD. *P < 0.05 versus control; ^†P < 0.05 versus CKD stage 2 to 4.

Figure 2.

VO₂ max in pediatric patients with CKD stage 2 to 4. Data represented as mean ± SD. *P < 0.05 versus control.

Figure 3.

(A) Heart rate and (B) respiratory quotient in pediatric patients with CKD at maximum exercise. Data represented as mean ± SD.